2023
DOI: 10.1016/j.hoc.2023.06.003
|View full text |Cite
|
Sign up to set email alerts
|

The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 64 publications
0
1
0
Order By: Relevance
“…Immunotherapy-using the immune system and its components to combat cancer has received considerable attention for many years with recent advancements elevating the enthusiasm for its potential to advance pediatric cancer care ( 1 , 2 ). Substantial focus has been placed on cellular therapy, with promising results observed to date ( 3 6 ). While investigations in this area continue, there remains a vast array of other strategies in using elements of the immune system that warrants further attention.…”
mentioning
confidence: 99%
“…Immunotherapy-using the immune system and its components to combat cancer has received considerable attention for many years with recent advancements elevating the enthusiasm for its potential to advance pediatric cancer care ( 1 , 2 ). Substantial focus has been placed on cellular therapy, with promising results observed to date ( 3 6 ). While investigations in this area continue, there remains a vast array of other strategies in using elements of the immune system that warrants further attention.…”
mentioning
confidence: 99%